0
Deep & Emerging Tech·September 24, 2026·1 min read

Precision Neuroscience raises $250m at a $1bn valuation, NYT reports

Share

A $250M Series D at a $1B valuation for a brain-computer interface company shows capital is willing to fund long-horizon neurotech, not just software. Health systems and device makers should start mapping where BCI could plug into existing care pathways rather than treating it as pure sci-fi.